Challenges Of Iranian Clinicians In Dealing With COVID-19: Taking Advantages Of The Experiences In Wenzhou
The novel coronavirus has been spreading since December 2019. It was initially reported in Wuhan, Hubei province of China. Coronavirus disease 2019 (COVID-19) has currently become a pandemic affecting over seven million people worldwide, and the number is still rising. Wenzhou, as the first hit city...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Royan Institute (ACECR), Tehran
2020-09-01
|
Series: | Cell Journal |
Subjects: | |
Online Access: | https://celljournal.org/journal/article/fulltext/challenges-of-iranian-clinicians-in-dealing-with-covid-19-taking-advantages-of-the-experiences-in-wenzhou.pdf |
id |
doaj-c6b383a8a7334062adf64aa4874a78ed |
---|---|
record_format |
Article |
spelling |
doaj-c6b383a8a7334062adf64aa4874a78ed2020-11-25T03:22:53ZengRoyan Institute (ACECR), TehranCell Journal2228-58062228-58142020-09-0122suppl 115516510.22074/cellj.2020.7604Challenges Of Iranian Clinicians In Dealing With COVID-19: Taking Advantages Of The Experiences In WenzhouYaser Tahamtani0Mehdi Totonchi1Chengshui Chen2Seyed Mohammad Reza Hashemian3Fatemeh Amoozegar4Jin-San Zhang5Yousef Gholampour6Xiaokun Li7Department of Diabetes, Obesity and Metabolism, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, IranDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, IranDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, ChinaChronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, IranNoncommunicable diseases research center, Fasa University of Medical Sciences, Fasa, IranDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, ChinaDepartment of Internal Medicine, School of Medicine, Fasa University of Medical Sciences, Fasa, IranDepartment of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, ChinaThe novel coronavirus has been spreading since December 2019. It was initially reported in Wuhan, Hubei province of China. Coronavirus disease 2019 (COVID-19) has currently become a pandemic affecting over seven million people worldwide, and the number is still rising. Wenzhou, as the first hit city out of Hubei Province, achieved a remarkable success in effectively containing the disease. A great record was also observed in Wenzhou for the clinical management of COVID-19 patients, leading to one of the lowest death rates in China. Researchers and clinical specialists proposed and formulated combined approaches such as computerized tomography (CT)- scans and molecular assays, as well as using both allopathic and traditional medications to mitigate its effects. Iranian and Chinese specialists and scientists had a communication in clinical, molecular and pharmaceutical aspects of COVID-19. A proper guideline was prepared according to the experiences of Chinese clinicians in managing the full spectrum of COVID-19 patients, from relatively mild to highly complex cases. The purpose of this guideline is to serve a reference in the hospital for specialists so that they may better diagnose cases and provide effective therapies and proposed antiviral and anti-inflammatory drugs for patients.https://celljournal.org/journal/article/fulltext/challenges-of-iranian-clinicians-in-dealing-with-covid-19-taking-advantages-of-the-experiences-in-wenzhou.pdfanti-inflammatory drugantiviral drugcovid-19diagnosissars-cov-2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yaser Tahamtani Mehdi Totonchi Chengshui Chen Seyed Mohammad Reza Hashemian Fatemeh Amoozegar Jin-San Zhang Yousef Gholampour Xiaokun Li |
spellingShingle |
Yaser Tahamtani Mehdi Totonchi Chengshui Chen Seyed Mohammad Reza Hashemian Fatemeh Amoozegar Jin-San Zhang Yousef Gholampour Xiaokun Li Challenges Of Iranian Clinicians In Dealing With COVID-19: Taking Advantages Of The Experiences In Wenzhou Cell Journal anti-inflammatory drug antiviral drug covid-19 diagnosis sars-cov-2 |
author_facet |
Yaser Tahamtani Mehdi Totonchi Chengshui Chen Seyed Mohammad Reza Hashemian Fatemeh Amoozegar Jin-San Zhang Yousef Gholampour Xiaokun Li |
author_sort |
Yaser Tahamtani |
title |
Challenges Of Iranian Clinicians In Dealing With COVID-19: Taking Advantages Of The Experiences In Wenzhou |
title_short |
Challenges Of Iranian Clinicians In Dealing With COVID-19: Taking Advantages Of The Experiences In Wenzhou |
title_full |
Challenges Of Iranian Clinicians In Dealing With COVID-19: Taking Advantages Of The Experiences In Wenzhou |
title_fullStr |
Challenges Of Iranian Clinicians In Dealing With COVID-19: Taking Advantages Of The Experiences In Wenzhou |
title_full_unstemmed |
Challenges Of Iranian Clinicians In Dealing With COVID-19: Taking Advantages Of The Experiences In Wenzhou |
title_sort |
challenges of iranian clinicians in dealing with covid-19: taking advantages of the experiences in wenzhou |
publisher |
Royan Institute (ACECR), Tehran |
series |
Cell Journal |
issn |
2228-5806 2228-5814 |
publishDate |
2020-09-01 |
description |
The novel coronavirus has been spreading since December 2019. It was initially reported in Wuhan, Hubei province of China. Coronavirus disease 2019 (COVID-19) has currently become a pandemic affecting over seven million people worldwide, and the number is still rising. Wenzhou, as the first hit city out of Hubei Province, achieved a remarkable success in effectively containing the disease. A great record was also observed in Wenzhou for the clinical management of COVID-19 patients, leading to one of the lowest death rates in China. Researchers and clinical specialists proposed and formulated combined approaches such as computerized tomography (CT)- scans and molecular assays, as well as using both allopathic and traditional medications to mitigate its effects. Iranian and Chinese specialists and scientists had a communication in clinical, molecular and pharmaceutical aspects of COVID-19. A proper guideline was prepared according to the experiences of Chinese clinicians in managing the full spectrum of COVID-19 patients, from relatively mild to highly complex cases. The purpose of this guideline is to serve a reference in the hospital for specialists so that they may better diagnose cases and provide effective therapies and proposed antiviral and anti-inflammatory drugs for patients. |
topic |
anti-inflammatory drug antiviral drug covid-19 diagnosis sars-cov-2 |
url |
https://celljournal.org/journal/article/fulltext/challenges-of-iranian-clinicians-in-dealing-with-covid-19-taking-advantages-of-the-experiences-in-wenzhou.pdf |
work_keys_str_mv |
AT yasertahamtani challengesofiraniancliniciansindealingwithcovid19takingadvantagesoftheexperiencesinwenzhou AT mehditotonchi challengesofiraniancliniciansindealingwithcovid19takingadvantagesoftheexperiencesinwenzhou AT chengshuichen challengesofiraniancliniciansindealingwithcovid19takingadvantagesoftheexperiencesinwenzhou AT seyedmohammadrezahashemian challengesofiraniancliniciansindealingwithcovid19takingadvantagesoftheexperiencesinwenzhou AT fatemehamoozegar challengesofiraniancliniciansindealingwithcovid19takingadvantagesoftheexperiencesinwenzhou AT jinsanzhang challengesofiraniancliniciansindealingwithcovid19takingadvantagesoftheexperiencesinwenzhou AT yousefgholampour challengesofiraniancliniciansindealingwithcovid19takingadvantagesoftheexperiencesinwenzhou AT xiaokunli challengesofiraniancliniciansindealingwithcovid19takingadvantagesoftheexperiencesinwenzhou |
_version_ |
1724608929079492608 |